All In MedTech

FDA Clearance Tracker · DEN240031

Prapela SVS hospital bassinet pad (model P01)

A De Novo grant creates a new device type for a low to moderate risk device with nothing on the market to compare it to. Later devices of this type can use it as their comparison in a 510(k).

Last checked: Nov 20, 2026Latest source record: Apr 4, 2025 (this decision)Source: openFDAMethods & limitations

De NovoNew device typeBreakthrough

Decided

Apr 4, 2025

De Novo granted

Time to decision

291 days

Received Jun 17, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

De Novo

Direct

Device class

Class II

The decision

FDA number
DEN240031
Device name
Prapela SVS hospital bassinet pad (model P01)
Applicant
Prapela, Inc.
Applicant location
Biddeford, ME
Received
Jun 17, 2024
Decided
Apr 4, 2025
Decision
De Novo granted
Submission type
Direct

Device type

Device class
Class II
Regulation
21 CFR 880.5151

Every decision under product code QVY

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

Other decisions for Prapela, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.